Literature DB >> 10822155

Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.

E Iseki1, W Marui, H Akiyama, K Uéda, K Kosaka.   

Abstract

We investigated the degeneration process of Lewy bodies (LB) in the brains of dementia with Lewy bodies, using alpha-synuclein-immunohistochemistry. Intracellular LB, LB-related neurites and some extracellular LB were positively immunostained with anti-alpha-synuclein antibodies. Concentric LB-bearing neurons had no microglial involvement, while degenerated neurons with ill-defined LB displayed intense microglial involvement. The late stage of extracellular LB were immunoelectron-microscopically composed of loose aggregates of filamentous components with lost alpha-synuclein-immunoreactivity and penetrated astroglial processes. These findings suggest that microglias are involved during the stages from degenerated LB-bearing neurons to extracellular LB, while astroglias are involved during the stage of extracellular LB. Some intracellular LB were positive for anti-C3d and -C4d antibodies, suggesting that the classical complement pathway is activated in degenerated LB-bearing neurons, inducing microglial activation and neuronal death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822155     DOI: 10.1016/s0304-3940(00)01090-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.

Authors:  Jorge Ghiso; Silvia Fossati; Agueda Rostagno
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Authors:  Douglas G Walker; Lih-Fen Lue; Tiffany M Tang; Charles H Adler; John N Caviness; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

3.  Evaluation of alpha-synuclein immunohistochemical methods used by invited experts.

Authors:  Thomas G Beach; Charles L White; Ronald L Hamilton; John E Duda; Takeshi Iwatsubo; Dennis W Dickson; James B Leverenz; Federico Roncaroli; Manuel Buttini; Christa L Hladik; Lucia I Sue; Joseph V Noorigian; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-07-15       Impact factor: 17.088

4.  Microglia in Alzheimer brain: a neuropathological perspective.

Authors:  Robert E Mrak
Journal:  Int J Alzheimers Dis       Date:  2012-05-13

5.  Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.

Authors:  David A Loeffler; Dianne M Camp; Stephanie B Conant
Journal:  J Neuroinflammation       Date:  2006-10-19       Impact factor: 8.322

Review 6.  Microglial pathology.

Authors:  Wolfgang J Streit; Qing-Shan Xue; Jasmin Tischer; Ingo Bechmann
Journal:  Acta Neuropathol Commun       Date:  2014-09-26       Impact factor: 7.801

7.  Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes.

Authors:  Gabriel Gustafsson; Veronica Lindström; Jinar Rostami; Eva Nordström; Lars Lannfelt; Joakim Bergström; Martin Ingelsson; Anna Erlandsson
Journal:  J Neuroinflammation       Date:  2017-12-11       Impact factor: 8.322

8.  Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates.

Authors:  Leonardo Acuña; Sabah Hamadat; Natalia S Corbalán; Florencia González-Lizárraga; Mauricio Dos-Santos-Pereira; Jérémy Rocca; Julia Sepúlveda Díaz; Elaine Del-Bel; Dulce Papy-García; Rosana N Chehín; Patrick P Michel; Rita Raisman-Vozari
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

9.  Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.

Authors:  Michela Deleidi; Walter Maetzler
Journal:  Int J Alzheimers Dis       Date:  2012-10-22

10.  Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

Authors:  Shi-Xun Ma; Bo Am Seo; Donghoon Kim; Yulan Xiong; Seung-Hwan Kwon; Saurav Brahmachari; Sangjune Kim; Tae-In Kam; Raja Sekhar Nirujogi; Sang Ho Kwon; Valina L Dawson; Ted M Dawson; Akhilesh Pandey; Chan Hyun Na; Han Seok Ko
Journal:  J Proteome Res       Date:  2021-06-01       Impact factor: 4.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.